CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 449677-449769 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Significant Rr6 pre beta-2-agonists and ? value reduction was obtained at T7 and T21 vs. T0.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T53717","span":{"begin":0,"end":92},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T53717","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T10","span":{"begin":0,"end":92},"obj":"Sentence"}],"attributes":[{"subj":"T10","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4490","span":{"begin":58,"end":61},"obj":"Disease"}],"attributes":[{"id":"A4490","pred":"mondo_id","subj":"T4490","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T4490","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ece593","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ca93ec"},{"id":"CORD-19-PD-MONDO","color":"#93ecb0"}]}]}}